Trial intelligence / Profile preview

Endovascular Treatment vs Medical Treatment for Chronic Intracranial Artery Occlusion

NCT07699003Not yet recruiting

Start
Aug 2026
Primary completion
Aug 2029
01

Overview

Randomised, single-blind trial in Intracranial artery occlusion (ICAO) (2 arms). Primary endpoint: Stroke or death within 30 days after enrollment, or any ischemic stroke of the qualifying artery after 30 days through 12 months after enrollment. Planned start Aug 2026; status: not yet recruiting.

02

Conditions

Intracranial artery occlusion (ICAO)

Beyond the preview

Go deeper on NCT07699003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07699003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call